Spectrum of cutaneous lesions in a cohort of patients with neurofibromatosis type 2
International Journal of Dermatology · 2025
DOI: 10.1111/ijd.17354 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Maria C Fialho und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dermatovenereology Department, Santo António dos Capuchos Hospital, Local Health Unit São José, Lisbon, Portugal. Hauptthemen laut MEDLINE: Neurofibromatosis 2, Skin Neoplasms, Hyperpigmentation, Hypopigmentation. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Background
Neurofibromatosis type 2 (NF2) is a rare autosomal dominant syndrome with a predisposition to the development of central nervous system tumors, ophthalmic manifestations, and dermatological lesions. The latter are present in 70–95% of patients and can precede the evolution of other tumors. However, they are not included in the diagnostic criteria and are frequently undervalued during follow‐up.
Methods
An observational cross‐sectional study characterizing cutaneous lesions in a cohort of NF2 patients was carried out. Dermatological examinations were performed, and lesions were classified into neural cutaneous tumors (superficial, SNCT, and deep, DNCT), hyperpigmented patches (HyperP), and hypopigmented patches (HypoP). The Dermatology Life Quality Index (DLQI) and EQ‐5D questionnaires were applied to evaluate the impact on quality of life.
Results
Nineteen patients with a mean age of 36 years were included. Sixteen (84%) patients had cutaneous lesions, mostly developed 10 or more years before the diagnosis. SNCT, DNCT, and HyperP showed similar frequencies (58%). HypoP were observed in only one patient. HyperP developed, on average, earlier than NCT (9.6 vs. 16.5 SNCT, 17.0 DNCT; years). The excised lesions had different histological patterns, including neurofibromas, schwannomas, and a hybrid tumor. Most patients reported a low impact of cutaneous manifestations on the quality of life (DLQI 0 or 1).
Conclusions
Cutaneous lesions are frequent in NF2 and may precede the diagnosis by several years. Their identification is important to establish the diagnosis earlier and potentially reduce morbidity and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatovenereology Department, Santo António dos Capuchos Hospital, Local Health Unit São José, Lisbon, Portugal.
- Dermatology Department, Portuguese Institute of Oncology Francisco Gentil, Lisbon, Portugal.
- Pathological Anatomy Department, Portuguese Institute of Oncology Francisco Gentil, Lisbon, Portugal.
- Neurology Department, Portuguese Institute of Oncology Francisco Gentil, Lisbon, Portugal.
ORCID-Profile: Maria C Fialho, Pedro M Garrido, Miguel Santos-Coelho, Ana Ferreirinha, Bárbara D Martins, João Passos, Cecília Moura
Zitieren
APA
Fialho, M. C., Garrido, P. M., Santos-Coelho, M., Ferreirinha, A., Martins, B. D., Passos, J., & Moura, C. (2025). Spectrum of cutaneous lesions in a cohort of patients with neurofibromatosis type 2. International Journal of Dermatology. https://doi.org/10.1111/ijd.17354
Vancouver
Fialho MC, Garrido PM, Santos-Coelho M, Ferreirinha A, Martins BD, Passos J, et al. Spectrum of cutaneous lesions in a cohort of patients with neurofibromatosis type 2. International Journal of Dermatology. 2025. doi:10.1111/ijd.17354
BibTeX
@article{Fialho2025,
author = {Fialho, Maria C and Garrido, Pedro M and Santos-Coelho, Miguel and Ferreirinha, Ana and Martins, Bárbara D and Passos, João and Moura, Cecília},
title = {Spectrum of cutaneous lesions in a cohort of patients with neurofibromatosis type 2},
journal = {International Journal of Dermatology},
year = {2025},
doi = {10.1111/ijd.17354}
}
EUVIMED